← Leaderboards
Michael K Racke
University Of Texas Sw Med Ctr/Dallas
$4,145,221
Attributed
$4,145,221
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $456.7K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$4,145,221 · 5
By mechanism
R01$3,502,037 · 2
K24$616,451 · 1
R13$25,000 · 1
M01$1,733 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Nitin J Karandikar$13,410,907
- Peter E Lipsky$1,069,221
- A. Dean Sherry$21,878,817
- Roger Rosenberg$8,764,462
- Michael J McPhaul$3,207,572
Others in their field
Top investigators on “Multiple Sclerosis”
- David A. Hafler · Brigham And Women'S Hospital$33,720,341
- Vijay K Kuchroo · Brigham And Women'S Hospital$32,935,587
- Stephen L Hauser · University Of California San Francisco$32,469,388
- Katerina Akassoglou · University Of California San Diego$24,525,425
- Abdolmohamad Rostami · Thomas Jefferson University$23,969,638
- Stephen D Miller · Northwestern University$23,969,272
Research focus
Multiple SclerosisT LymphocyteLeukocyte Activation /TransformationHuman SubjectClinical ResearchCytokineMyelinMyelinopathyPhenotypeLaboratory MousePathologic ProcessFundingCellsImmuneBaseNeuroimmunomodulationDrug Screening /EvaluationImmunopathology ChemotherapyImmune Tolerance /UnresponsivenessInflammationMitoxantroneCopolymer IDisease /Disorder EtiologyGenetically Modified Animals
Grant awards (20)
T cell activation requirement in autoimmune demyelination$375,000
R01 · FY2010 · NS · contact PI
T cell activation requirement in autoimmune demyelination$375,000
R01 · FY2009 · NS · contact PI
Immunopathogenesis of Multiple Sclerosis$128,911
K24 · FY2008 · NS · contact PI
Ninth International Congress of Neuroimmunology$25,000
R13 · FY2008 · NS · contact PI
CLINICAL TRIAL: BETASERON/BETAFERON IN MS$1,733
M01 · FY2008 · RR · contact PI
T cell activation requirement in autoimmune demyelinatio$325,614
R01 · FY2006 · NS · contact PI
Immunopathogenesis of Multiple Sclerosis$108,700
K24 · FY2006 · NS · contact PI
Immunopathogenesis of Multiple Sclerosis$17,433
K24 · FY2006 · NS · contact PI
T cell activation requirement in autoimmune demyelinatio$333,450
R01 · FY2005 · NS
Immunopathogenesis of Multiple Sclerosis$123,245
K24 · FY2005 · NS
T cell activation requirement in autoimmune demyelinatio$333,450
R01 · FY2004 · NS
Immunopathogenesis of Multiple Sclerosis$120,442
K24 · FY2004 · NS
Tcell activation requirement in autoimmune demyelination$333,450
R01 · FY2003 · NS
Immunopathogenesis of Multiple Sclerosis$117,720
K24 · FY2003 · NS
T CELL ACTIVATION IN AUTOIMMUNE DEMYELINATION$278,905
R01 · FY2002 · NS
MECHANISM OF COPAXONE THERAPY IN MS$183,412
R01 · FY2002 · AI
T CELL ACTIVATION IN AUTOIMMUNE DEMYELINATION$270,715
R01 · FY2001 · NS
MECHANISM OF COPAXONE THERAPY IN MS$217,991
R01 · FY2001 · AI
T CELL ACTIVATION IN AUTOIMMUNE DEMYELINATION$262,763
R01 · FY2000 · NS
MECHANISM OF COPAXONE THERAPY IN MS$212,287
R01 · FY2000 · AI